| NO. |
Product Name |
Cas No. |
Structure |
Standard
Usage
Station |
| 3 |
(S)-1-(4-Nitrophenyl)ethylamine hydrochloride
|
57233-86-0 |
 |
Ambrisentan |
| 4 |
2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate-1-methanesulfonate
|
134877-42-2 |
 |
Gemcitabine |
| 5 |
toluene-4-sulfonic acid 3-propionylphenyl ester
|
1369205-80-0 |
 |
Tapentadol |
| 6 |
5-Formamide-1-(2-formyloxyethl)pyrazole
|
116856-18-9 |
 |
Cefoselis |
| 7 |
Diphenylmethyl 7beta-Tert-Butoxycarbonylamino-3-Chloromethyl-3-Cephem-4-Carboxylate
|
112028-91-8 |
 |
Cefoselis |
| 8 |
4-AMino-2-Methyl-10H-thienol[2.3-B][1.5]benzodiazepine hydrochloride
|
138564-60-0 |
 |
Olanzapine |
| 11 |
(S)-Butyl 2-hydroxybutanoate
|
132513-51-0 |
 |
Pemafibrate |
| 12 |
3-(4-methoxyphenoxy)propan-1-amine
|
100841-00-7 |
 |
Pemafibrate |
| 13 |
1-Adamantanol
|
768-95-6 |
 |
Adapalene |
| 16 |
1-Bromo-3,5-Dimethyladamantane
|
941-37-7 |
 |
Memantine HCl |
| 17 |
1,3-Dimethyladamantane
|
702-79-4 |
 |
Memantine HCl |
| 18 |
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan
|
915095-89-5 |
 |
Empagliflozin |
| 19 |
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
|
915095-94-2 |
 |
Empagliflozin |
| 20 |
(S)-Tetrahydrofuran-3-ol
|
86087-23-2 |
 |
Empagliflozin |
| 20 |
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol
|
1985607-83-7 |
 |
Baloxavir |
| 21 |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl] thiophene
|
898566-17-1 |
 |
Canagliflozin |
| 21 |
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
|
1985607-70-2 |
 |
Baloxavir |
| 22 |
6-bromo-3-hydroxypyrazine-2-carboxamide
|
259793-88-9 |
 |
favipiravir |
| 23 |
(R)-3-(Boc-amino)piperidine
|
309956-78-3 |
 |
Linagliptin |
| 23 |
Methyl 3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
|
1358715-37-3 |
 |
Retgliptin |
